• Nachrichtendetail
• 

18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	MERCK CO. DL-,01	A0YD8Q	Xetra	119,200	03.07.24 09:26:14	+0,800	+0,68%	119,000	119,800	119,200	118,400
	LIGAND PHARMAC.NEW DL-001	A1C9RN	Frankfurt	78,500	03.07.24 08:15:10	±0,000	±0,00%	78,500	79,500	78,500	78,500